For general inquiries, call 1 877-564-0008 or inquiries@heliusmedical.com. Fax PoNS device prescriptions to 1 215-754-4903.
PoNS
For Patients PT Training
How PoNS Works What to Expect with PoNS PoNS Real Stories PoNS Resources
Find a Clinic About News + Events Contact

News + Events

TitleDate
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy™Jul 12, 2022
Helius Medical Technologies, Inc. Presents Poster at the 2022 Consortium of Multiple Sclerosis Centers (“CMSC”) Annual MeetingJun 6, 2022
Helius Medical Technologies, Inc. Announces Launch of Patient Therapy Access Program for PoNS®Jun 1, 2022
Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual ConferenceMay 31, 2022
Helius Medical Technologies, Inc. Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®May 12, 2022
Helius Medical Technologies, Inc. Fulfills First U.S. Prescriptions for PoNS®Apr 27, 2022
Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking AbilityApr 26, 2022
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®Dec 14, 2021
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial SiteNov 8, 2021
Helius Medical, Inc. Receives U.S. Marketing Authorization for the PoNS™ DeviceMar 29, 2021
Helius Medical Technologies, Inc. Announces Formation of Multiple Sclerosis Scientific Advisory BoardOct 8, 2020
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple SclerosisMay 12, 2020
PoNS

For Patients

  • How PoNS Works
  • PoNS Rate Your Gait
  • PoNS Real Stories
  • PoNS Resources
  • About
  • News + Events
  • Find a Clinic
  • Contact
  • Privacy Policy
  • Terms + Conditions

For general inquiries, contact us by phone at 1 877-564-0008 or via email at inquiries@heliusmedical.com.

Please fax PoNS device prescriptions to 1 215-754-4903.

INDICATIONS

The PoNS® device is indicated for use as a short term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis and is to be used as an adjunct to a supervised therapeutic exercise program for adults 22 years of age and over by prescription only.

CONTRAINDICATIONS

The PoNS® device delivers electrical stimulation directly to the surface of the tongue. Precautions for use are similar to those for transcutaneous electrical nerve stimulation (TENS).

Electrical stimulation should not be used:

  • If there is an active or suspected malignant tumor
  • In areas of recent bleeding or open wounds
  • In areas that lack normal sensation
The PoNS® has not been tested on, and thus should not be used by individuals who are pregnant. Do not use the PoNS® if you are sensitive to nickel, gold or copper.
© Copyright 2022 | Helius Medical Technologies.